Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TAIKO PHARMACEUTICAL CO LTD Raises Consolidated Full-year Outlook for FY 2013


Thursday, 7 Feb 2013 01:00am EST 

TAIKO PHARMACEUTICAL CO LTD announced that it has raised its consolidated full-year outlook for revenue from JPY 6,500 million to JPY 7,100 million, operating profit from JPY 550 million to JPY 850 million, ordinary profit from JPY 530 million to JPY 900 million, net profit from JPY 500 million to JPY 730 million and earning per share from JPY 38.58 to JPY 57.28, for the fiscal year ending March 2013. The positive outlook is due to the increased sales. 

Company Quote

1885.0
-31.0 -1.62%
2:00am EDT